214 related articles for article (PubMed ID: 26542803)
1. MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1.
Hong CF; Lin SY; Chou YT; Wu CW
J Biol Chem; 2016 Jan; 291(4):1877-1889. PubMed ID: 26542803
[TBL] [Abstract][Full Text] [Related]
2. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.
Arts FA; Keogh L; Smyth P; O'Toole S; Ta R; Gleeson N; O'Leary JJ; Flavin R; Sheils O
Hum Pathol; 2017 Dec; 70():98-104. PubMed ID: 29079174
[TBL] [Abstract][Full Text] [Related]
3. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis.
Shen J; Xiao Z; Wu WK; Wang MH; To KF; Chen Y; Yang W; Li MS; Shin VY; Tong JH; Kang W; Zhang L; Li M; Wang L; Lu L; Chan RL; Wong SH; Yu J; Chan MT; Chan FK; Sung JJ; Cheng AS; Cho CH
Cancer Res; 2015 Feb; 75(4):754-65. PubMed ID: 25503559
[TBL] [Abstract][Full Text] [Related]
5. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Pfister NT; Fomin V; Regunath K; Zhou JY; Zhou W; Silwal-Pandit L; Freed-Pastor WA; Laptenko O; Neo SP; Bargonetti J; Hoque M; Tian B; Gunaratne J; Engebraaten O; Manley JL; Børresen-Dale AL; Neilsen PM; Prives C
Genes Dev; 2015 Jun; 29(12):1298-315. PubMed ID: 26080815
[TBL] [Abstract][Full Text] [Related]
7. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
[TBL] [Abstract][Full Text] [Related]
8. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
[TBL] [Abstract][Full Text] [Related]
10. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
Cao JX; Lu Y; Qi JJ; An GS; Mao ZB; Jia HT; Li SY; Ni JH
Cell Death Dis; 2014 Sep; 5(9):e1426. PubMed ID: 25255219
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.
Zheng ZH; Wu DM; Fan SH; Zhang ZF; Chen GQ; Lu J
J Cell Biochem; 2019 Nov; 120(11):18724-18735. PubMed ID: 31219199
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells.
Lin CC; Liao WT; Yang TY; Lu HJ; Hsu SL; Wu CC
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165168
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells.
Jiang L; Chang J; Zhang Q; Sun L; Qiu X
Cancer Invest; 2013 Oct; 31(8):538-44. PubMed ID: 24044511
[TBL] [Abstract][Full Text] [Related]
14. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
15. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
17. BAF60a interacts with p53 to recruit the SWI/SNF complex.
Oh J; Sohn DH; Ko M; Chung H; Jeon SH; Seong RH
J Biol Chem; 2008 May; 283(18):11924-34. PubMed ID: 18303029
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
19. hsa-miR-100-5p, an overexpressed miRNA in human ovarian endometriotic stromal cells, promotes invasion through attenuation of SMARCD1 expression.
Takebayashi K; Nasu K; Okamoto M; Aoyagi Y; Hirakawa T; Narahara H
Reprod Biol Endocrinol; 2020 Apr; 18(1):31. PubMed ID: 32299427
[TBL] [Abstract][Full Text] [Related]
20. The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma.
Peinado P; Andrades A; Martorell-Marugán J; Haswell JR; Slack FJ; Carmona-Sáez P; Medina PP
Hum Mol Genet; 2021 Nov; 30(23):2263-2271. PubMed ID: 34240140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]